Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:35 PM
Study NCT ID:
NCT02567851
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2015-09-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity
Sponsor:
University of Birmingham